Prestige Consumer Healthcare Inc. (PBH)
Market Cap | 3.28B |
Revenue (ttm) | 1.11B |
Net Income (ttm) | 208.60M |
Shares Out | 49.53M |
EPS (ttm) | 4.12 |
PE Ratio | 16.07 |
Forward PE | 13.61 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 277,720 |
Open | 65.67 |
Previous Close | 65.76 |
Day's Range | 65.58 - 66.99 |
52-Week Range | 48.51 - 67.45 |
Beta | 0.59 |
Analysts | Buy |
Price Target | 71.06 (+7.36%) |
Earnings Date | Feb 2, 2023 |
About PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wa... [Read more]
Financial Performance
In 2022, PBH's revenue was $1.09 billion, an increase of 15.21% compared to the previous year's $943.37 million. Earnings were $205.38 million, an increase of 24.71%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is $71.06, which is an increase of 7.36% from the latest price.
News

Prestige Brands (PBH) Q3 Earnings and Revenues Surpass Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 2.97% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare Inc. Reports Third Quarter Results
TARRYTOWN, N.Y., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third fiscal quarter ended December 31, 2022.

Prestige Consumer (PBH) to Post Q3 Earnings: Factors to Consider
Prestige Consumer (PBH) third-quarter fiscal 2023 earnings might reflect gains from brand-building strategies, e-commerce business and market share gains.

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results
TARRYTOWN, N.Y., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 third quarter earnings release on Thursday, February ...

4 Consumer Products-Discretionary Stocks to Watch Amid Industry Headwinds
Prestige Consumer Healthcare (PBH), Central Garden & Pet (CENT), Traeger (COOK) and The RealReal (REAL) have been focusing on superior product strategy and prudent capital investments.

Prestige Consumer (PBH) Q2 Earnings Beat Mark, Revenues Rise
Prestige Consumer's (PBH) second-quarter fiscal 2023 results were backed by strength in its brand portfolio and solid business strategy.

Prestige Brands (PBH) Tops Q2 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 2% and 2.24%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023
TARRYTOWN, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second fiscal quarter ended September 30, 2022.

Factors to Know Ahead of Prestige Consumer (PBH) Q2 Earnings
Prestige Consumer's (PBH) second-quarter fiscal 2023 earnings results might reflect the impacts of a tough operating landscape, including supply-chain headwinds and higher costs.

Earnings Preview: Prestige Brands (PBH) Q2 Earnings Expected to Decline
Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results
TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November...

5 Stocks to Buy on Rise in Personal Income, Personal Spending
Despite rising costs, people are spending aggressively as personal income is on the rise, helping stocks like Marriott Vacations (VAC), Hyatt Hotels (H), Prestige Consumer Healthcare (PBH), InterConti...

Here's Why Prestige Brands (PBH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Consumer Confidence Soars for Second Straight Month: 4 Picks
Stocks like Prestige Consumer Healthcare Inc. (PBH), RCI Hospitality Holdings, Inc. (RICK), Hyatt Hotels Corporation (H) and On Holding AG (ONON) may gain as Americans seem to be regaining their lost ...

The 7 Most Undervalued Mid-Cap Stocks to Buy Now
It's up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities are...

PBH vs. VZIO: Which Stock Is the Better Value Option?
PBH vs. VZIO: Which Stock Is the Better Value Option?

Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference
TARRYTOWN, N.Y., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) will present at the 2022 Barclays Global Consumer Staples Conference on Thursday, September 8, 2022 at ...

Prestige Consumer (PBH) Brands & E-commerce Strength Bode Well
Prestige Consumer Healthcare's (PBH) solid brand portfolio and e-commerce growth keep the company well-placed.

Down 12.1% in 4 Weeks, Here's Why Prestige Brands (PBH) Looks Ripe for a Turnaround
Prestige Brands (PBH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings esti...

Prestige Brands (PBH) Moves to Buy: Rationale Behind the Upgrade
Prestige Brands (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PBH vs. VZIO: Which Stock Should Value Investors Buy Now?
PBH vs. VZIO: Which Stock Is the Better Value Option?

Prestige Consumer (PBH) Q1 Earnings Top Estimates, Revenues Up
Prestige Consumer Healthcare's (PBH) first-quarter fiscal 2023 results reflect increased revenues thanks due to strength in key brands, while earnings decline year over year.

Prestige Brands (PBH) Beats Q1 Earnings and Revenue Estimates
Prestige Brands (PBH) delivered earnings and revenue surprises of 5.83% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
TARRYTOWN, N.Y., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its first fiscal quarter ended June 30, 2022.

Prestige Consumer (PBH) Queued for Q1 Earnings: Things to Note
Prestige Consumer's (PBH) first-quarter fiscal 2023 performance will likely reflect the impacts of escalated inflationary environment and supply-chain issues.